MoCRA Compliance Articles

Analysis and updates on mocra compliance matters from Anthony Girand, Esq.

Visit the MoCRA Compliance Attorney Page
MoCRANov 16, 2026

Beyond the Lab: Building a Defensible Safety Substantiation File

MoCRA doesn't dictate specific tests—it demands a scientifically defensible safety record. Here's how indie brands build one that actually holds up.

Read More
MoCRANov 13, 2026

Managing Your Biennial MoCRA Facility Registration Renewal: A Step-by-Step Guide

A practical, step-by-step walkthrough for founders navigating the Cosmetics Direct portal to verify and complete their mandatory MoCRA biennial facility renewal.

Read More
MoCRANov 10, 2026

Beyond Registration: 10 Essential MoCRA Compliance Pillars for Indie Brands

MoCRA's small business exemption covers only registration and listing. Indie founders remain fully liable for safety substantiation, adverse event reporting, and labeling.

Read More
MoCRANov 9, 2026

Decoding the FDA’s Finalized Mandatory Cosmetic Recall Guidance

FDA's October 2026 final guidance turns MoCRA's mandatory recall authority into operational reality—here's how responsible persons should prepare now.

Read More
MoCRANov 6, 2026

Building Your Safety Substantiation File: A Practical Guide for Indie Brands

A practical, budget-conscious roadmap for indie cosmetic founders to compile MoCRA-compliant safety substantiation files without costly clinical trials.

Read More
MoCRANov 6, 2026

Debunking FDA Compliance Certificates: What E-commerce Platforms Actually Need

FDA doesn't issue 'compliance certificates' for cosmetics—here's what MoCRA actually requires and how to respond to platform demands without faking paperwork.

Read More
MoCRAOct 29, 2026

The Small Business Trap: MoCRA Exemptions You Cannot Afford to Ignore

Small cosmetic brands may dodge MoCRA registration and GMP rules, but safety substantiation and adverse event reporting apply regardless of size.

Read More
MoCRAOct 26, 2026

Preparing for FDA Mandatory Recalls: A New MoCRA Enforcement Reality

FDA's October 2026 final guidance on MoCRA mandatory recall authority signals tighter timelines and less tolerance for delay—here's how to prepare.

Read More
MoCRAOct 23, 2026

Avoiding the Drug Trap: Marketing Claims and MoCRA Compliance

One careless phrase in your marketing copy can legally transform your cosmetic into an unapproved drug. Here's how founders can avoid the trap.

Read More
MoCRAOct 20, 2026

Building a Compliant Adverse Event Intake System for Indie Brands

A practical, founder-focused roadmap for building an adverse event intake system that meets MoCRA's strict 15-business-day FDA reporting deadline.

Read More
MoCRAOct 18, 2026

Mastering Fragrance Allergen Labeling: Preparing for Upcoming MoCRA Disclosure Mandates

FDA's forthcoming fragrance allergen disclosure rule under MoCRA will reshape cosmetic labeling—here's how founders can prepare before the mandate takes effect.

Read More
MoCRAOct 14, 2026

FDA’s 2026 Draft Guidance on Mandatory Cosmetic Recall Authority

FDA's 2026 draft guidance signals a new era of mandatory cosmetic recalls under MoCRA—here's what Responsible Persons must do to prepare now.

Read More
MoCRAOct 13, 2026

Clarifying FDA Registration Status: Why Listing Numbers Are Not Compliance Certificates

FDA registration numbers under MoCRA confirm administrative compliance—not product safety or regulatory approval. Misrepresenting this distinction invites serious enforcement exposure.

Read More
MoCRAOct 13, 2026

Leveraging the FAERS Dashboard for Proactive Cosmetic Safety Risk Mitigation

MoCRA has made cosmetic adverse event data public—companies that treat the dashboard as business intelligence, not paperwork, gain a decisive risk management advantage.

Read More
MoCRAOct 12, 2026

Leveraging the FAERS Public Dashboard for Proactive Cosmetic Safety Monitoring

MoCRA's new reporting mandates and FDA's public adverse event dashboards demand proactive monitoring—companies that wait for enforcement letters have already fallen behind.

Read More
MoCRAOct 9, 2026

Shaping Future Cosmetic GMPs: Engaging in FDA’s New Rulemaking Process

FDA's forthcoming cosmetic GMP rules will reshape manufacturing compliance for years—stakeholders who stay silent during this rulemaking window risk losing their voice entirely.

Read More
MoCRAOct 5, 2026

Navigating PFAS Disclosure: Analyzing FDA’s 2026 Cosmetic Safety Report Findings

FDA's 2026 PFAS cosmetic safety report raises the bar for MoCRA safety substantiation and signals a new wave of product liability exposure for brand owners.

Read More
MoCRASep 30, 2026

Addressing PFAS Liability: Navigating Emerging MoCRA Safety Substantiation Standards

FDA findings on PFAS in cosmetics are reshaping MoCRA compliance expectations, exposing gaps in safety substantiation files and heightening litigation risk.

Read More
MoCRASep 26, 2026

Managing E-commerce Platform Demands for Non-Existent FDA Compliance Certificates

E-commerce platforms demand FDA compliance certificates for cosmetics that the agency simply does not issue—creating a costly compliance gap under MoCRA.

Read More
MoCRASep 21, 2026

U.S. Cosmetics Regulatory Brief: What MoCRA Requires Now

FDA has confirmed it issues no MoCRA registration certificates, even as facility renewals, annual listing reviews, and Washington's formaldehyde-releaser ban arrive on individualized deadlines.

Read More
MoCRASep 20, 2026

Managing Asbestos Liability in Talc Cosmetics Following FDA’s Rule Withdrawal

FDA's withdrawal of its MoCRA talc-testing rule creates a compliance vacuum—cosmetic brands should adopt dual-microscopy testing now, not wait until 2026.

Read More
MoCRASep 17, 2026

Navigating the 2026 Biennial Cosmetic Facility Registration Renewal Cycle

As FDA enhances Cosmetics Direct with new status tracking, cosmetic facilities must proactively manage the 2026 biennial renewal cycle to avoid compliance gaps.

Read More
MoCRASep 13, 2026

MoCRA Contract Manufacturing Agreements: Managing Responsible Person and Supply Chain Liabilities

MoCRA has transformed cosmetics supply agreements into regulatory risk instruments—here's how brands and contract manufacturers should reallocate liability.

Read More
MoCRASep 11, 2026

MoCRA Litigation Risk: Defending Against FDA FAERS Public Dashboard Scrutiny

FDA's public FAERS cosmetic dashboard is reshaping MoCRA compliance into a litigation-readiness function—here's how Responsible Persons can get ahead of the risk.

Read More
MoCRASep 3, 2026

Decoding FDA’s New Safety Substantiation Burden Estimates for 2026 Compliance

FDA's updated burden-hour estimates for MoCRA safety substantiation reveal a demanding new documentation standard—one companies must address well before 2026.

Read More
MoCRAAug 30, 2026

Preparing for FDA Fragrance Allergen Labeling: A Proactive Compliance Strategy

FDA's fragrance allergen rule is coming—companies that audit formulations against EU standards now will avoid costly, last-minute reformulations later.

Read More
MoCRAAug 26, 2026

Preparing for FDA Mandatory Cosmetic Recalls: A Strategic Compliance Framework

MoCRA's new mandatory recall authority ends the FDA's reliance on voluntary compliance—companies must now build recall readiness directly into their regulatory strategy.

Read More
MoCRAAug 12, 2026

Managing the 2026 Biennial MoCRA Facility Registration Renewal Cycle

As the first MoCRA biennial renewal approaches, companies must audit Cosmetics Direct data now to avoid registration inaccuracies and suspension risk.

Read More
MoCRAAug 6, 2026

Navigating the 2026 Biennial MoCRA Facility Registration Renewal Cycle

As the first MoCRA biennial renewal window opens in 2026, cosmetic manufacturers must audit facility registration data now to avoid enforcement exposure.

Read More
MoCRAJul 27, 2026

Defending MoCRA Preemption: Analyzing 2026 Court Rulings on State Safety Standards

As federal courts confront a wave of 2026 MoCRA preemption rulings, the line between permissible state disclosure laws and preempted safety mandates is rapidly taking shape.

Read More
MoCRAJul 15, 2026

MoCRA Records Access: Managing Risks During FDA Remote Regulatory Assessments

FDA's expanded MoCRA authority to demand records during remote audits creates real enforcement risk. We outline the legal strategies cosmetic brands need now.

Read More
MoCRAJun 1, 2026

MoCRA: Understanding the New Facility Registration Requirements

The Modernization of Cosmetics Regulation Act requires every cosmetic facility to register with FDA and renew every two years. Here is what brands, contract manufacturers, and importers need to know.

Read More
MoCRAMay 31, 2026

Cosmetic Labeling Under MoCRA: Fragrance Allergens, PFAS, and What's Coming

MoCRA updates cosmetic labeling rules and sets the stage for future requirements on fragrance allergen disclosure and PFAS. Brands must prepare for a new labeling landscape.

Read More
MoCRAApr 18, 2026

MoCRA Product Listing Guide

An overview of MoCRA's cosmetic product listing requirement, including what information must be submitted to the FDA and how to keep listings current.

Read More
MoCRAApr 16, 2026

MoCRA in 2026 and Startup Law Essentials: What Every Cosmetics Brand and Early-Stage Company Must Know

The Modernization of Cosmetics Regulation Act is reshaping how cosmetics reach the market — and the legal exposure that comes with noncompliance is growing fast. At the same time, startup founders face legal pitfalls that can cripple a young company before it ever reaches scale. This article addresses both.

Read More
MoCRAApr 13, 2026

MoCRA and Adverse Event Reporting: What Cosmetic Brands Must Do

MoCRA mandates reporting serious adverse events to FDA within 15 business days and retaining records for six years. Understanding these obligations is essential for any responsible person.

Read More
MoCRAApr 3, 2026

MoCRA Facility Registration Guide

What cosmetic manufacturers and processors need to know about MoCRA facility registration requirements, deadlines, and how to stay compliant with the FDA.

Read More
MoCRAApr 1, 2026

MoCRA for Small Businesses and Importers: Key Compliance Considerations

MoCRA's reach extends to small cosmetic businesses and foreign importers. Understanding who is covered, what exemptions apply, and how to structure compliance is critical for these companies.

Read More
MoCRAMar 30, 2026

MoCRA Labeling, Fragrance Allergens, and PFAS Issues

A look at MoCRA's cosmetic labeling requirements, the new fragrance allergen disclosure rules, and emerging PFAS concerns facing cosmetic companies.

Read More
MoCRAMar 23, 2026

MoCRA Facility Registration Deadlines: What Cosmetic Manufacturers Must Do Now

MoCRA facility registration and product listing requirements remain a top compliance priority for cosmetic manufacturers in 2026.

Read More
MoCRAMar 22, 2026

Cosmetic Product Labeling Under MoCRA: Avoiding Common Compliance Pitfalls

MoCRA introduced new labeling obligations for cosmetic products, including fragrance allergen disclosure. Here's how to avoid common mistakes.

Read More
MoCRAFeb 15, 2026

Adverse Event Reporting Under MoCRA: Building a Compliant System

MoCRA's adverse event reporting requirements demand a formal internal process. Here's how cosmetic companies can build one that holds up.

Read More
MoCRAJan 7, 2026

Cosmetic Safety Substantiation and GMP: What MoCRA Requires

MoCRA requires responsible persons to maintain adequate safety substantiation for every cosmetic product. FDA is also finalizing Good Manufacturing Practice regulations. Here is how to prepare.

Read More